Furthermore, our results showed that cardiac Cdc42 deficiency ameliorated TAC-induced cardiac hypertrophy and inhibited TAC-induced increases in the expression of hypertrophic genes such as ANP and BNP (Fig. 6A-D). This evidence concerns the gene CDC42 and cardiac hypertrophy.